TFRC and chronic myelogenous leukemia, BCR-ABL1 positive: Barabas and Faulk [43] have shown that doxorubicin-resistant human chronic myelogenous leukemia cells (K562) and promyelocytic leukemia cells (HL60) have up-regulated transferrin receptor (TfR) expression.